Evidence map›Paper›PMID 34534445›Full record

ArticleCell2021

Genome-wide functional screen of 3'UTR variants uncovers causal variants for human disease and evolution.

Dustin Griesemer, James R Xue, Steven K Reilly, Jacob C Ulirsch, Kalki Kukreja, Joe R Davis, Masahiro Kanai, David K Yang, John C Butts, Mehmet H Guney and 6 more

Open access · greenAbstract read
In one paragraph

Article in Cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 2 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 2 syntheses or guidelines pooled it, 179 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. TACR3 variant confers resilience to aging and Alzheimer's disease.medRxiv : the preprint server for health sciences · 2026
    Article
  9. Article
  10. Review
  11. Genetic polymorphisms of theFrontiers in genetics · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Dustin GriesemerBroad Institute of MIT and Harvard, Cambridge, MA 02143, USA; Program in Bioinformatics and Integrative Genomics, Harvard Medical School, Boston, MA 02115, USA; Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
James R XueBroad Institute of MIT and Harvard, Cambridge, MA 02143, USA; Department Of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02143, USA. Electronic address: jxue@broadinstitute.org.
Steven K ReillyBroad Institute of MIT and Harvard, Cambridge, MA 02143, USA; Department Of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02143, USA.
Jacob C UlirschBroad Institute of MIT and Harvard, Cambridge, MA 02143, USA; Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA 02115, USA; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
Kalki KukrejaDepartment of Molecular and Cell Biology, Harvard University, Cambridge, MA 02138, USA.
Joe R DavisBigHat Biosciences, San Carlos, CA 94070, USA.
Masahiro KanaiBroad Institute of MIT and Harvard, Cambridge, MA 02143, USA; Program in Bioinformatics and Integrative Genomics, Harvard Medical School, Boston, MA 02115, USA; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
David K YangBroad Institute of MIT and Harvard, Cambridge, MA 02143, USA.
John C ButtsThe Jackson Laboratory, Bar Harbor, ME 04609, USA; Graduate School of Biomedical Sciences and Engineering, University of Maine, Orono, ME 04469, USA.
Mehmet H GuneyProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Jeremy LubanBroad Institute of MIT and Harvard, Cambridge, MA 02143, USA; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Stephen B MontgomeryDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
Hilary K FinucaneBroad Institute of MIT and Harvard, Cambridge, MA 02143, USA; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
Carl D NovinaBroad Institute of MIT and Harvard, Cambridge, MA 02143, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Ryan TewheyThe Jackson Laboratory, Bar Harbor, ME 04609, USA; Graduate School of Biomedical Sciences and Engineering, University of Maine, Orono, ME 04469, USA; Tufts University School of Medicine, Boston, MA 02111, USA.
Pardis C SabetiBroad Institute of MIT and Harvard, Cambridge, MA 02143, USA; Department Of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02143, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
Broad Institute · USHarvard University · USJackson Laboratory · USStanford University · USTufts University · USUniversity of Massachusetts Chan Medical School · US

Funding

Comprehensive functional characterization and dissection of noncoding regulatory elements and human genetic variationUM1HG009435 · NHGRI · BROAD INSTITUTE, INC. · PI SABETI, PARDIS CHRISTINE · 2017 to 2021
$6.6M
The HUSH complex in HIV-1 latencyR37AI147868 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI JEREMY LUBAN · 2019 to 2026
$6.4M
Massively Parallel Phenotypic Characterization of Non-coding Genetic VariationR00HG008179 · NHGRI · JACKSON LABORATORY · PI TEWHEY, RYAN · 2018 to 2020
$747k
Comprehensive Characterization of Adaptive Regulatory Variation Linked to Human DiseaseR00HG010669 · NHGRI · YALE UNIVERSITY · PI REILLY, STEVEN K. · 2021 to 2023
$737k
Comprehensive Characterization of Adaptive Regulatory Variation Linked to Human DiseaseK99HG010669 · NHGRI · BROAD INSTITUTE, INC. · PI REILLY, STEVEN K. · 2019 to 2020
$250k
Leveraging Tissue-Specific Regulatory Grammar to Interpret Human Evolution and Non-coding VariationF32HG009226 · NHGRI · HARVARD UNIVERSITY · PI REILLY, STEVEN K. · 2016 to 2019
$160k
Genome-wide validation of posttranscriptional variation in selection and diseaseF30GM114940 · NIGMS · HARVARD MEDICAL SCHOOL · PI GRIESEMER, DUSTIN SHAHAB · 2015 to 2017
$133k
Howard Hughes Medical InstituteNHGRI NIH HHS F32 HG009226NHGRI NIH HHS K99 HG010669NHGRI NIH HHS R00 HG008179NHGRI NIH HHS R00 HG010669NHGRI NIH HHS UM1 HG009435NIAID NIH HHS R37 AI147868NIGMS NIH HHS F30 GM114940
6 · The paper itself

Abstract

3' untranslated region (3'UTR) variants are strongly associated with human traits and diseases, yet few have been causally identified. We developed the massively parallel reporter assay for 3'UTRs (MPRAu) to sensitively assay 12,173 3'UTR variants. We applied MPRAu to six human cell lines, focusing on genetic variants associated with genome-wide association studies (GWAS) and human evolutionary adaptation. MPRAu expands our understanding of 3'UTR function, suggesting that simple sequences predominately explain 3'UTR regulatory activity. We adapt MPRAu to uncover diverse molecular mechanisms at base pair resolution, including an adenylate-uridylate (AU)-rich element of LEPR linked to potential metabolic evolutionary adaptations in East Asians. We nominate hundreds of 3'UTR causal variants with genetically fine-mapped phenotype associations. Using endogenous allelic replacements, we characterize one variant that disrupts a miRNA site regulating the viral defense gene TRIM14 and one that alters PILRB abundance, nominating a causal variant underlying transcriptional changes in age-related macular degeneration.

Indexed as

Biological EvolutionGenome-Wide Association Study3' Untranslated RegionsAlgorithmsAllelesDiseaseGene Expression RegulationGenes, ReporterGenetic VariationHumansPhenotypePolymorphism, Single NucleotidePolyribosomesQuantitative Trait LociRNA3' Untranslated RegionsRNA3'UTRevolutionfunctional genomicsgenetic variantsGWASMPRAregulatory genomics

Identifiers

PMID34534445
PMCPMC8487971
OpenAlexW3201233585

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.